Serenoa repens vs placebo or no intervention
Adverse eventsCumulative incidence · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Serenoa repens showed no clear difference in adverse eventsCumulative incidence compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
- Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes onlyRR 1.01 [0.77, 1.31]12 studies · 2399 participantsModerate